<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM OF THE STUDY: To determine the occurrence of intestinal and extraintestinal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> in the 1993-2009 prospective European Collaborative <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">Inflammatory Bowel Disease</z:e> (EC-IBD) Study Group cohort </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS-METHODS: A physician per patient form was completed for 681 inflammatory <z:e sem="disease" ids="C0021831" disease_type="Disease or Syndrome" abbrv="">bowel disease</z:e> patients (445UC/236CD) from 9 centers (7 countries) derived from the original EC-IBD cohort </plain></SENT>
<SENT sid="2" pm="."><plain>For the 15-year follow up period, rates of detection of intestinal and extraintestinal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> were computed </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Patient follow-up time was fifteen years </plain></SENT>
<SENT sid="4" pm="."><plain>In total 62/681 patients (9.1%) [41 with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>/21 with <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo>, 36 males/26 females] were diagnosed with sixty-six <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (four patients with double <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>) </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> was diagnosed in 9/681 patients [1.3%] (1 <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> and 8 <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>) </plain></SENT>
<SENT sid="6" pm="."><plain>The remaining 53 cancers were extraintestinal </plain></SENT>
<SENT sid="7" pm="."><plain>There was a higher prevalence of <z:e sem="disease" ids="C0346627" disease_type="Neoplastic Process" abbrv="">intestinal cancer</z:e> in the Northern centers compared to Southern centers [p=NS] </plain></SENT>
<SENT sid="8" pm="."><plain>Southern centers had more cases of extraintestinal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> compared to Northern centers [p=NS] </plain></SENT>
<SENT sid="9" pm="."><plain>The frequency of <z:hpo ids='HP_0000001'>all</z:hpo> observed types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> in Northern and in Southern centers did not differ compared to the expected one in the background population </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: In the fifteen-year follow up of the EC-IBD Study Group cohort the prevalence of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> was 9.1% with most patients having a single <z:hpo ids='HP_0002664'>neoplasm</z:hpo> and an extraintestinal <z:hpo ids='HP_0002664'>neoplasm</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>In Northern centers there were more <z:e sem="disease" ids="C0346627" disease_type="Neoplastic Process" abbrv="">intestinal cancers</z:e> while in Southern centers there were more extraintestinal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> compared to Northern centers </plain></SENT>
<SENT sid="12" pm="."><plain>In this IBD cohort the frequency of observed <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> was not different from that expected in the background population </plain></SENT>
</text></document>